The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy

Table 1

General characteristics of the study groups divided into MS patients (RRMS) and healthy people (control).

Group	RRMS	Control
N	121	41	0.157
Age (years)	37.5 ± 14	36 ± 21	0.588
Gender (% of females)	66.94	78.05	0.181

RRMS: relapsing-remitting multiple sclerosis; statistical significance for .